Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00159406 · ClinicalTrials.gov registry record
Laser Prostatectomy Database and Registry
A clinical trial of Benign Prostatic Hyperplasia and Enlarged Prostate, sponsored by Indiana Kidney Stone Institute.
- Active
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT00159406: Active study of Benign Prostatic Hyperplasia and Enlarged Prostate, sponsored by Indiana Kidney Stone Institute.
NCT00159406 is a study of Benign Prostatic Hyperplasia and Enlarged Prostate that is active but no longer recruiting, run by Indiana Kidney Stone Institute. The registered enrollment target is 3,000 participants, above the 449-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (568% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00159406, a study of Benign Prostatic Hyperplasia and Enlarged Prostate, is active but no longer recruiting, sponsored by Indiana Kidney Stone Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
STATEMENT OF PURPOSE: Transurethral resection of the prostate (TURP) is the standard surgical intervention for obstructive benign prostatic hyperplasia (BPH) in all but the largest of glands, which are typically treated with open simple prostatectomy. Recently, new generation lasers (holmium and potassium titanyl phosphate \[KTP\]) have been utilized for BPH treatment. Long-term follow-up of laser prostatectomy outcomes must be documented to fully characterize the degree of voiding improvement achievable by these new techniques, the durability of these outcomes, and the safety profiles of these procedures.
Conditions Studied
Interventions
- OTHER Registry and Database
Study Locations (1)
Indiana
- IU Health Methodist Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2003-10 |
| Est. Completion | 2025-12 |
What the registry record for NCT00159406 still lists
NCT00159406 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 449-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (568% higher).
The record links to 2 conditions, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 1 intervention - of which Registry and Database is the first listed.
NCT00159406 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT00159406 about?
NCT00159406 is a clinical study titled "Laser Prostatectomy Database and Registry". STATEMENT OF PURPOSE: Transurethral resection of the prostate (TURP) is the standard surgical intervention for obstructive benign prostatic hyperplasia (BPH) in all but the largest of glands, which are typically treated with open simple prostatectomy. Recently, new generation lasers (holmium and po...
What is the current status of trial NCT00159406?
This trial is currently active not recruiting. The enrollment target is 3,000 participants. The study started on 2003-10. Estimated completion is 2025-12.
What conditions does trial NCT00159406 study?
This clinical trial studies the following conditions: Benign Prostatic Hyperplasia, Enlarged Prostate.
What interventions are being tested in trial NCT00159406?
The interventions under investigation include: Registry and Database (OTHER).
Who is sponsoring clinical trial NCT00159406?
This trial is sponsored by Indiana Kidney Stone Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00159406 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Benign Prostatic Hyperplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00159406's enrollment target sits among peer trials
3,000 2nd of 29 the highest of 29 other Benign Prostatic Hyperplasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Benign Prostatic Hyperplasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Customized TULSA-PRO Ablation Registry
RECRUITING
-
OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH
RECRUITING
-
Ambulatory Long Length URodynamics Evaluation
RECRUITING · NA
-
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia